CorMedix Inc. (CRMD)
Health Care ยท Pharmaceutical Preparations
CorMedix Inc. (CRMD) is listed on Nasdaq, where its shares have traded since May 13, 2010. SentiSense covers CorMedix Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. The company reports 191 employees, and its corporate website is www.cormedix.com.
About CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Latest reported results
CorMedix Inc. reported revenue of $101.9 million for Q2 FY2026, up 156.5% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 183 institutions reported holding CRMD, with 43.5 million shares worth $341.4 million in aggregate. The largest reported holders were BlackRock, Deep Track Capital and Vanguard. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
More on CRMD
- CRMD sentiment: whether news and social coverage of CorMedix Inc. leans bullish or bearish, and the stories driving it.
- CRMD ownership: all 183 reporting institutions, plus insider and congressional trades.
- CRMD financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for CorMedix Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does CorMedix Inc. do?
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions.
What sector is CRMD in?
SentiSense classifies CorMedix Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does CRMD stock trade?
CorMedix Inc. (CRMD) is listed on Nasdaq, where its shares have traded since May 13, 2010.
How many institutions own CRMD?
183 institutions reported a position in CRMD in 13F filings for the quarter ended June 30, 2026, worth $341.4 million in total.